{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:48:57Z","timestamp":1760546937553},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1016\/s0959-8049(01)00075-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:59:10Z","timestamp":1027619950000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":25,"title":["The BRCA1 syndrome and other inherited breast or breast\u2013ovarian cancers in a Norwegian prospective series"],"prefix":"10.1016","volume":"37","author":[{"given":"P.","family":"M\u00f8ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Heimdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Apold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vallon-Christersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hovig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"M\u00e6hle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(01)00075-2_BIB1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/301639","article-title":"Inherited mutations in PTEN associated with beast cancer, Cowden disease and juvenile polyposis","volume":"61","author":"Lynch","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/jnci\/90.23.1824","article-title":"Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history","volume":"90","author":"Claus","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB4","doi-asserted-by":"crossref","unstructured":"Sobol H, Eisinger F, Stoppa-Lyonnet D, et al. Histoprognostic grade in hereditary breast cancer: is inheritance linked to BRCA1 a bad prognostic factor? In Muller H, Scott RJ, Weber W. Hereditary Cancer. 2nd Int. Res. Conf. on Familial Cancer, Basel, 1995. Basel, Karger, 1996, 11\u201318.","DOI":"10.1159\/000425551"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactonal analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB7","first-page":"782","article-title":"The pathology of familial breast cancer","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB8","first-page":"94","article-title":"Genetic cancer; a challenge and a possible strategy","volume":"2","author":"M\u00f8ller","year":"1993","journal-title":"J. Cancer Care"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/j.1600-0412.1999.781013.x","article-title":"Prospectively detected cancer in familial breast\/ovarian cancer screening","volume":"78","author":"D\u00f8rum","year":"1999","journal-title":"Acta Gyn. Obst. Scand."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0960-9776(98)90053-4","article-title":"Prospective findings in breast cancer kindreds. Annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer","volume":"7","author":"M\u00f8ller","year":"1998","journal-title":"The Breast"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1155\/1999\/278269","article-title":"Two BRCA1 founder mutations, 1135insA and 1675delA, account for one third of Norwegian familial breast-ovarian cancer, and may have lower penetrance than infrequent mutations","volume":"15","author":"Borg","year":"1999","journal-title":"Dis. Markers"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB12","first-page":"1068","article-title":"Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer","volume":"60","author":"Hakansson","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1999.6026","article-title":"Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations","volume":"62","author":"Wagner","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(98)03300-5","article-title":"Population-based study of risk of breast cancer in carriers of BRCA2 mutation","volume":"352","author":"Thorlacius","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1155\/1999\/920109","article-title":"Guidelines for follow-up of women at high risk for inherited breast cancer. Consensus statement from the Biomed2 Demonstration Programme on Inherited Breast Cancer","volume":"15","author":"M\u00f8ller","year":"1999","journal-title":"Dis. Markers"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1155\/1999\/605917","article-title":"Utilisation of prophylactic mastectomy in 10 European centres","volume":"15","author":"Evans","year":"1999","journal-title":"Dis. Markers"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1086\/302530","article-title":"Penetrances of BRCA1 l675delA and 1 l35insA with respect to breast and ovarian cancer","volume":"65","author":"D\u00f8rum","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0959-8049(01)00075-2_BIB19","series-title":"Familial Cancer. First Int. Res. Conf. on Familial Cancer, Basel, 1985","first-page":"20","article-title":"Breast Cancer Genetics","author":"Lynch","year":"1985"},{"key":"10.1016\/S0959-8049(01)00075-2_BIB20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1155\/1999\/805420","article-title":"Efficacy of early diagnosis and treatment in women with a family history of breast cancer","volume":"15","author":"M\u00f8ller","year":"1999","journal-title":"Dis. Mar."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T13:53:40Z","timestamp":1580219620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804901000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0959804901000752"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(01)00075-2","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}